에 대한 최신 뉴스 Flywire (NASDAQ:FLYW) 주식

Flywire

Flywire Corp provides a secure payment platform, offering its clients a streamlined process to receive reconciled domestic and international payments more cost-effectively and efficiently. The company's solutions are built on three core elements namely a payments platform; a proprietary global payment network and vertical-specific software backed by its deep industry expertise. Geographically, the majority of revenue is from the Americas.

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

FLYW

TOST

UPST

2024년 11월 8일 기준, 금융 섹터의 3종목의 주식이 모멘텀을 중요하게 여기는 투자자들에게 실질적인 경고 신호를 보낼 수 있다. 상대 강도 지수(RSI)는 모멘텀 지표로, 주가가 상승하는 날의 강도와 하락하는 날의 강도를 비교한다. 주가 행동과 비교할 때, 주식이 단기적으로 어떻게 수행될 수 있는지를 더 잘 이해할 수 있다. Benzinga Pro에 따르면, 일반적으로 RSI가 70 이상일 때 자산이 과매수 상태로 간주된다.

이번 달에 절벽으로 떨어질 수 있는 상위 3개의 금융주

Flywire Corporation - Voting Common Stock

Flywire Corp

FLYWHEEL ADVANCED TECH by Flywheel Advanced Technology Inc.

Flywheel Advanced Technology Inc

According to the <a href="https://www.benzinga.com/real-estate/24/11/41710617/the-fed-cut-rates-so-why-are-mortgage-rates-climbing-the-truth-behind-the-housing-markets-latest-cur">Mortgage </a>Bankers Association (MBA), mortgage demand took a sharp dive, with applications plummeting 11% as interest rates hovered above 7%. The MBA's Chief Economist, Mike Fratantoni, remarked that affordability is being squeezed tightly and first-time buyers, particularly, are feeling the heat.&nbsp;
Don't Miss:
<ul>
<li>This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.</li>
<li>‘Beating the market through ethical real estate investing' —<a href="https://www.benzinga.com/money/invest-with-roots"> this platform aims to give tenants equity in the homes they live in while scoring 17.38% average annual returns for investors – here&#8217;s how to join with just $100</a></li>
</ul>
"Homebuyers, particularly first-time buyers who do not have the ability to make larger down payments, have been more willing to accept a higher payment burden," Fratantoni commented. The average 30-year fixed-rate mortgage peaked in May at 7.2%, keeping some potential buyers on the sidelines and leaving those dependent on financing in a pinch.
The squeeze on buyers reflects the sixth week of declining mortgage applications, showing just how much the current rate environment has cooled off what was previously a red-hot market. Joel Kan, an economist with the MBA, noted, "Purchase activity has fallen to its lowest level since mid-August and refinance activity has hit its lowest since May."&nbsp;
Trending: During market downturns, investors are learning that unlike equities, these<a href="https://www.benzinga.com/money/connect-invest-real-estate-notes"> high-yield real estate notes that pay 7.5% &#8211; 9% are protected by resilient assets, buffering against losses.</a>
 He explained that refinancing is particularly rate-sensitive; as a result, refinance applications dropped 19% in just one week, though they remain 48% higher than the same week last year.
"Most people refinancing are looking for immediate relief, but even those with larger loans are opting out now," Kan noted.
"They're susceptible to even slight changes in rates." He pointed out that the average refinance loan size has dropped below $300,000, signaling that borrowers with larger debts may hesitate to lock in rates at this level.&nbsp;
The impact doesn't stop with refinance applicants. Mortgage applications for home purchases also slid, dipping 5% for the week and barely registering a 2% increase from last year.&nbsp;
See Also: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
According to Kan, home-buying activity has seen a boost over recent months as more inventory becomes available and prices ease a bit, but the recent rate hikes seem to be pricing some buyers right back out. "People are simply less willing to leap into a new mortgage with such high rates. The<a href="https://www.benzinga.com/personal-finance/24/11/41728751/even-as-inflation-cools-most-americans-cant-get-ahead-and-continue-living-paycheck-to-paycheck-r"> higher costs</a> are turning what would have been a manageable purchase into a hard sell," he observed.
Experts are mixed on where rates might head in the near term, but there's some cautious optimism for 2024. Analysts at S&amp;P Global Ratings expect mortgage rates to gradually ease and if that pans out, the housing market may find some breathing room.&nbsp;
Read Next:
<ul>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." <a href="https://www.benzinga.com/money/connect-invest-real-estate-notes">These high-yield real estate notes that pay 7.5% &#8211; 9% make earning passive income easier than ever.</a></li>
</ul>

Real Estate

With Interest Rates Soaring, Weekly Mortgage Demand Nosedives 11% – A Warning Sign For The Real Estate Market?

Roth MKM analyst George Kelly reiterates Beachbody Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BODI#NYSE">BODI</a>) with a Buy and maintains $12 price target.

Price Target

Reiteration

Analyst Ratings

The Beachbody Company, Inc. Class A Common Stock

BODI

Roth MKM Reiterates Buy on Beachbody Co, Maintains $12 Price Target

Shares of Cisco Systems Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) declined in early trading on Thursday, even after the company reported <a href="https://www.benzinga.com/news/earnings/24/11/41955614/cisco-q1-earnings-revenue-beat-eps-beat-strong-start-to-year-customers-investing-in-ai-and-more">upbeat fiscal first-quarter earnings</a>.
The company reported its results amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
<ul>
<li>Goldman Sachs <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5a1c4e20efacff00015a984c/michael-ng">analyst Michael Ng</a> maintained a Neutral, while raising the price target higher from $51 to $56.</li>
<li>Piper Sandler <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5a09e167efacff00012b1912/james-fish">analyst James Fish</a> reiterated a Neutral, while lifting the price target from $52 to $57.</li>
<li>Morgan Stanley <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58933b2143eaaa0001698f54/meta-marshall">analyst Meta Marshall</a> reaffirmed an Overweight rating, while raising the price target from $58 to $62.</li>
</ul>
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Goldman Sachs: Cisco Systemsreported its fiscal first-quarter earnings at 91 cents per share, higher than consensus of 87 cents per share, with the beat being driven by better-than-expected gross margins and in-line revenue of $13.8 billion, Ng said in a note. Order growth ex-Splunk accelerated to 9% year-on-year, with 17% growth in Enterprise and 22% in Service Provider &amp; Cloud, he added.
"Webscale, which is a subset within Service Provider &amp; Cloud, was a bright spot with orders growing triple digits," including more than $300 million of AI orders, the analyst wrote. The AI momentum puts Cisco Systems "well on track" to exceed its fiscal 2025 target of $1 billion in AI orders, he further stated.
Piper Sandler: Cisco Systems posted total revenues of $13.84 billion, which represents a 6% year-on-year decline but came in higher than expectations by around 1%, Fish said. "The upside again came via Product, though primarily was due to ~ $20M higher Splunk contribution," he further wrote.
Management raised their annual revenue guidance by $200 million at the midpoint, "given the demand environment, but more likely the upside of recurring Splunk revenue," the analyst stated. This led Cisco Systems to raise its earnings guidance to $3.60-$3.66 per share, he added.
Morgan Stanley: Cisco Systems reported higher-than-expected quarterly results, largely due to Splunk's outperformance, Marshall said. "Upending on networking is improving coming out of inventory digestion," he added.
The company benefited from "meaningful traction" across three AI investments, the first being more than $300 million in AI orders, the analyst stated. Second was double digit growth in networking orders due to improving connectivity ahead of AI and the third was "in terms of data center modernization for enterprises ahead of AI investments," he further wrote.
Price Action: Shares of Cisco Systems had declined by 1.30% to $58.41 at the time of publication on Thursday.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41939200/cisco-earnings-on-deck-as-ai-cybersecurity-drive-growth-potential">Cisco Earnings On Deck As AI, Cybersecurity Drive Growth Potential</a></li>
</ul>
Image: Shutterstock

Analyst Color

Earnings Beats

Movers

CSCO

Cisco Systems Analysts Raise Forecasts On 'Meaningful Traction' Across 3 AI Investments

Roth MKM analyst Bill Kirk maintains Ayr Wellness (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AYRWF#OTC">AYRWF</a>) with a Buy and lowers the price target from $3.5 to $3.

AYRWF

Roth MKM Maintains Buy on Ayr Wellness, Lowers Price Target to $3

RBC Capital analyst Drew McReynolds maintains Boat Rocker Media (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BRMI#TSX">BRMI</a>) with a Outperform and lowers the price target from C$2.5 to C$1.5.

TSX:BRMI

RBC Capital Maintains Outperform on Boat Rocker Media, Lowers Price Target to C$1.5

RBC Capital analyst James McGarragle maintains CAE (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CAE#TSX">CAE</a>) with a Outperform and raises the price target from C$27 to C$34.

TSX:CAE

RBC Capital Maintains Outperform on CAE, Raises Price Target to C$34

Scotiabank analyst Phil Hardie maintains Element Fleet Mgmt (TSX:<a class="ticker" href="https://www.benzinga.com/stock/EFN#TSX">EFN</a>) with a Sector Outperform and lowers the price target from C$33 to C$32.

TSX:EFN

Scotiabank Maintains Sector Outperform on Element Fleet Mgmt, Lowers Price Target to C$32

RBC Capital analyst Pammi Bir maintains Crombie REIT (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CRR#TSX">CRR</a>) with a Sector Perform and raises the price target from C$15 to C$16.

TSX:CRR

TSX:CRR/UN

RBC Capital Maintains Sector Perform on Crombie REIT, Raises Price Target to C$16

Scotiabank analyst Divya Goyal maintains Converge Tech Solns (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CTS#TSX">CTS</a>) with a Sector Perform and lowers the price target from C$5 to C$4.

TSX:CTS

Scotiabank Maintains Sector Perform on Converge Tech Solns, Lowers Price Target to C$4

Hims &amp; Hers Health Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) shares are trading lower in possible response to Amazon.com Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) new upfront pricing for <a href="https://www.benzinga.com/topic/telehealth">telehealth visits and treatment plans</a>. 
What Happened: Amazon announced Thursday that its Amazon One Medical telehealth service is introducing low upfront pricing for clinical visits and treatment plan, as well as free medication delivery for Prime members.
Prime members can now see the total monthly cost or individual use cost for Amazon One Medical Pay-per-visit virtual visits and medications from the Amazon Pharmacy before signing up for care.
"This simple care experience was built to meet the needs of today's customer. At Amazon, we're working to reduce the burden on patients who'd like to move forward with care, but may be tired of navigating the hurdles of our health care system, waiting in a long line at the pharmacy, or worried about a surprise bill or medication cost," said Vin Gupta, chief medical officer for Amazon Pharmacy. 
Prime members who use Amazon Pharmacy will pay a low, upfront price for medications and get those medications delivered for free for a range of common health, beauty and lifestyle concerns including anti-aging skin care treatment, men&#8217;s hair loss, erectile dysfunction and motion sickness.
See Also: <a href="https://www.benzinga.com/general/biotech/24/11/41964382/amazons-secret-fertility-tracker-project-launched-under-jeff-bezos-reportedly-halted-amid-ceo-andy-jassys-cost-cutting-drive">Amazon&#8217;s Secret Fertility Tracker Project Launched Under Jeff Bezos Reportedly Halted Amid CEO Andy Jassy&#8217;s Cost-Cutting Drive</a>
Hims &amp; Hers Health shares moved lower on the news. The company&#8217;s strategy involves bringing customers convenient, transparent and affordable access to care. 
In the third quarter, Hims &amp; Hers subscribers jumped 44% year-over-year to 2 million. The company&#8217;s revenue was up 77% year-over-year to $401.6 million, and Hims &amp; Hers raised its full-year outlook to $1.46 billion to $1.465 billion.
&#8220;Our model is rapidly gaining scale, driving accelerating top line growth, improving profitability and strong cash flow. We are seeing this strength across our business,&#8221; CFO Yemi Okupe said in the earnings release.
HIMS Price Action: <a href="http://benzinga.com/quote/HIMS">Hims &amp; Hers Health shares</a> were down 13.8% at $23.77 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Pixabay.

AMZN

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Hims & Hers Health Stock Is Tumbling Thursday: What's Going On?

International Flavors &amp; Fragrances, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFF#NYSE">IFF</a>) shares are trading lower on Thursday. The company launched TEXSTAR, which is an enzymatic solution that enhances the texture of dairy and plant-based fermented products by building<a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n41964577/iff-launches-texstar-pioneering-enzyme-set-to-transform-fresh-fermented-food-textures" rel="noreferrer noopener"> viscosity without added stabilizers</a>.
TEXSTAR allows manufacturers to achieve distinctive textures with simple, consumer-friendly ingredients, while improving supply chain resilience and reducing Scope 3 emissions associated with texturants.
Marianne Toftdal, global product line manager, Dairy Enzymes, IFF, said, &#8220;With nearly two-thirds of U.K. consumers scrutinizing yogurt ingredients as closely as other foods, TEXSTAR&nbsp;allows the creation of delicious, fresh fermented products with creamy, velvety textures that consumers love, using familiar and consumer-accepted ingredients.&#8221;&nbsp;
This month, International Flavors reported a third-quarter adjusted EPS of $1.04, missing the $1.08 estimate, while sales reached $2.92 billion, surpassing <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b41758164/iff-reports-third-quarter-2024-results" rel="noreferrer noopener">the $2.83 billion expectation</a>.
Investors can gain exposure to the stock via&nbsp;iShares Emergent Food and AgTech Multisector ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVEG#NASDAQ">IVEG</a>) and Investment Managers Series Trust III FPA Global Equity ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/FPAG#BATS">FPAG</a>).
Price Action: IFF shares are down 1.71% at $88.31 at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41852733/fragrance-maker-iff-positioned-for-growth-with-revitalized-rd-and-attractive-valuation-analyst" target="_blank" rel="noreferrer noopener">Fragrance Maker IFF Positioned For Growth With Revitalized R&amp;D And Attractive Valuation: Analyst</a></li>
</ul>

Equities

Northern Lights Fund Trust III FPA Global Equity ETF

FPAG

IVEG

IFF's New TEXSTAR Solution Enhances Texture, Cuts Emissions In Dairy & Plant-Based Foods

Wells Fargo &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) shares are up 13% to $73 since the beginning of November. The stock has seen marked strength following Donald Trump's <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41772701/trumps-historic-return-7-ways-his-second-term-could-impact-the-us-economy">presidential election win</a>, as investors anticipate that his administration's economic policies could create a favorable climate for major banks. 
Trump&#8217;s tax agenda, which includes potential expansions to the 2017 Tax Cuts and Jobs Act, could lower corporate tax rates further, directly boosting Wells Fargo's earnings. 
Given Wells Fargo's large domestic footprint, the bank stands to benefit substantially from reduced tax burdens, which would improve net income and possibly free up additional funds for shareholder returns through dividends or buybacks.
Read Also: <a href="https://www.benzinga.com/24/11/41971559/disneys-q4-boosted-by-streaming-gains-strong-box-office-and-solid-parks-performance">Disney Q4 Earnings: Revenue And Profit Beat, Best Film Studio Performance, 3-Year Outlook And More</a>
What To Know: Trump's stance on regulatory reform is another factor likely driving optimism for Wells Fargo. Under his previous administration, Trump aimed to ease financial industry regulations, including parts of the Dodd-Frank Act, which could lead to a similar approach this time. This deregulation could be advantageous for Wells Fargo as it looks to recover from recent operational and compliance challenges. 
Eased oversight and reduced compliance costs would allow Wells Fargo to focus on core banking activities like consumer lending, small business support and expanding its mortgage portfolio, without the same intensity of regulatory constraints that have limited its growth in recent years.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41971830/producer-inflation-rises-more-than-expected-in-october-should-traders-rethink-interest-rate-cut-path">Producer Inflation Rises More Than Expected In October: Should Traders Rethink Interest Rate Cut Path?</a>
What Else: In addition, Trump's economic policies may create inflationary pressures, especially with proposed spending increases and high tariffs on imported goods. This could prompt the Federal Reserve to keep interest rates elevated, an outcome that would positively impact Wells Fargo's profitability. 
As a bank with a large base of consumer and business loans, Wells Fargo benefits from higher net interest margins when rates are elevated, as it can charge more for lending while controlling deposit costs.
Overall, the combination of potential tax savings, regulatory relief and a higher-rate environment under Trump's policies creates an optimistic outlook for Wells Fargo.
Read Also: <a href="https://www.benzinga.com/news/buybacks/24/11/41971497/tapestry-and-capri-call-off-8-5b-deal-amid-legal-hurdles">Tapestry And Capri Call Off $8.5B Deal Amid Legal Hurdles</a>
<h2 class="wp-block-heading">How To Buy WFC Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Wells Fargo&#8217;s case, it is in the Financials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

What's Going On With Wells Fargo (WFC) Shares

Scotiabank analyst Konark Gupta maintains CAE (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CAE#TSX">CAE</a>) with a Sector Perform and raises the price target from C$30 to C$32.5.

Scotiabank Maintains Sector Perform on CAE, Raises Price Target to C$32.5

Hedge Funds

General

WYNN

Amended 13G Shows Tilman Fertitta Increased Stake In Wynn Resorts From 6.22% To 9.9%

RBC Capital analyst James McGarragle maintains Exchange Income (TSX:<a class="ticker" href="https://www.benzinga.com/stock/EIF#TSX">EIF</a>) with a Outperform and raises the price target from C$65 to C$71.

TSX:EIF

RBC Capital Maintains Outperform on Exchange Income, Raises Price Target to C$71

Intuitive Machines Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) shares are volatile Thursday on the heels of the company&#8217;s third-quarter financial results. Here&#8217;s a <a href="https://www.benzinga.com/pressreleases/24/11/g41968968/intuitive-machines-reports-third-quarter-2024-results">rundown of the report</a>.
What To Know: Intuitive Machines reported third-quarter revenue of $58.48 million, beating analyst estimates of $50.89 million, according to<a href="http://pro.benzinga.com"> Benzinga Pro</a>. Total revenue was up 359% on a year-over-year basis.
The company reported a net loss of $80.44 million, versus net income of $14.31 million in the prior year&#8217;s quarter. Backlog grew to $316.2 million in the quarter, the highest in company history. Intuitive Machines ended the quarter with $89.6 million in cash.
&#8220;Intuitive Machines had a very strong&nbsp;third quarter&nbsp;highlighted by key wins, revenue growth, and the largest cash balance in Company history,&#8221; said Steve Altemus, CEO of Intuitive Machines.
&#8220;We made progress across all three pillars by first securing another south pole lunar delivery mission, then winning the Near Space Network Services contract, and finally, continuing to mature both our LTV design in conjunction with our heavy cargo class lander. These strategic revenue streams bring our business thesis clearly into view, allowing us to focus on capturing more operational services, which we believe will provide long-tail revenues with higher margins.&#8221;
Intuitive Machines' moon lander Odysseus made history in February when it touched down on the surface of the moon, making Intuitive Machines the first private company to land on the moon and bringing the U.S. back to the moon for the first time since 1972.
Intuitive Machines said it completed a vehicle propulsion system hot fire for its second lunar mission during the third quarter. The company said it&#8217;s targeting the launch of its second lunar mission in the first quarter.
See Also: <a href="https://www.benzinga.com/general/space/24/11/41961309/rocket-lab-ceo-touts-spacex-rival-status-trump-impact-on-space-as-stock-surges-almost-30">Rocket Lab CEO Touts SpaceX Rival Status, Trump Impact On Space As Stock Surges Almost 30%</a>
Outlook: Intuitive Machines narrowed its full-year revenue outlook to a range of $215 million to $235 million. The company also said it expects continued backlog expansion driven by potential upcoming awards including Near Space Network 1.2 / 1.3 Direct to Earth and LTVS Phase 2, as well as task orders for OMES and Near Space Network 2.2.
Management is currently discussing the quarter on a conference call with investors that kicked off at 8:30 a.m. ET.
LUNR Price Action: <a href="http://benzinga.com/quote/lunr">Intuitive Machines shares</a> were down 7.36% at $10.90 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: courtesy of Intuitive Machines.

Earnings

SPACE

LUNR

Intuitive Machines Stock Volatile On Q3 Earnings: What You Need To Know

Scotiabank analyst Mario Saric maintains Artis REIT (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AX#TSX">AX</a>) with a Sector Perform and raises the price target from C$7 to C$7.5.

TSX:AX

TSX:AX/UN

Scotiabank Maintains Sector Perform on Artis REIT, Raises Price Target to C$7.5

AC Immune SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACIU#NASDAQ">ACIU</a>) revealed data from a Phase 2 clinical trial of its wholly owned anti-alpha-synuclein (a-syn) active immunotherapy candidate for <a href="https://www.benzinga.com/pressreleases/24/11/g41967487/ac-immune-reports-positive-interim-results-from-phase-2-trial-of-aci-7104-056-active-immunotherapy" target="_blank" rel="noreferrer noopener">early Parkinson&#8217;s disease</a>.
Dr. Andrea Pfeifer, CEO of AC Immune, commented: &#8220;The level of immunogenicity after only 3 months of treatment as well as the continued positive safety profile, reinforces the best-in-class characteristics of our clinically validated anti-a-syn active immunotherapy for the treatment of Parkinson&#8217;s disease. We look forward to sharing further updates in H1 2025 including the decision to expand into Part 2 of the VacSYn study.&#8221;
VacSYn is an adaptive, placebo-controlled, and biomarker-based Phase 2 study in patients with early PD, consisting of two parts.
Part 1 includes initial analyses from over 30 patients randomized to receive ACI-7104.56 or placebo.
To date, no clinically relevant safety issues have been reported other than transient injection site reactions (49%) and headaches (18%).
Interim results show positive antibody responses were effectively induced against the target antigen at week 6 after two immunizations and were strongly boostable.
Treatment with the candidate, ACI-7104.056, induced an increase in anti-a-syn antibodies on average 16-fold higher than the placebo background level after three immunizations.
Based on further interim results, including pharmacodynamic data, to be reported in H1 2025, AC Immune may decide to initiate Part 2 of VacSYn with up to 150 patients.
Patients from Part 2 will also be evaluated for the progression of motor and non-motor symptoms of the disease, as well as digital, imaging, and fluid biomarkers.
In May, Takeda&nbsp;Pharmaceutical Company Limited&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAK#NYSE">TAK</a>)&nbsp;and&nbsp;AC Immune announced an exclusive, worldwide option and license agreement for AC Immune's active immunotherapies targeting toxic forms of amyloid beta (Abeta), including ACI-24.060&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/05/38797408/why-is-small-cap-alzheimers-focused-ac-immune-stock-trading-higher-on-monday" rel="noreferrer noopener">for Alzheimer's disease</a>.
Price Action: AC Immune stock is up 6.71% at $3.34 during the premarket session at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/41951274/nutanix-catalysts-include-hci-growth-vmware-market-share-shift-and-ai-demand-analyst" target="_blank" rel="noreferrer noopener">Nutanix Catalysts Include HCI Growth, VMware Market Share Shift, And AI Demand: Analyst</a></li>
</ul>

Biotech

Health Care

ACIU

AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients

Macro Economic Events

Econ #s

Economics

Natural Gas Storage Build Of 42B Vs 34B Est.; 69B Prior

The S&amp;P 500 Index has traded higher and posted new all-time highs since the 2024 presidential election was<a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election"> won by Donald Trump.</a>
Benzinga readers expect the momentum to continue, with the index nearing impressive election year milestones.
What Happened: The 2024 presidential election win by Donald Trump has created market optimism <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41784504/trumps-win-sends-indices-to-record-highs-financials-small-caps-surge-bitcoin-tops-75-000-w">across the stock market </a>and cryptocurrency sector.
While analysts and experts look for individual stocks and sectors that could benefit under four years with Trump beginning in January 2025, market indexes have soared to record levels.
The SPDR S&amp;P 500 ETF Trust (ARCA :SPY), which tracks the S&amp;P 500 Index, opened for trading at $570.74 on Election Day and closed at $576.70 the same day, ahead of Americans and people around the world knowing the election outcome.
By early morning on Nov. 6, media outlets had declared Trump the winner of the election, and the SPY opened at $589.20, up 2.2% from the previous day.
A recent poll of Benzinga readers shows that market optimism is expected since the Trump victory was declared.
"Will Trump's victory keep the stock market on a winning streak through 2024?" Benzinga asked.
The results were:
<ul>
<li>Yes: 76%</li>
<li>No: 24%</li>
</ul>
The majority of Benzinga readers expect the stock market momentum to continue after Trump's victory, likely meaning that the S&amp;P 500 will continue to gain through the end of the year.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent111424">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/23/12/36416440/why-buy-stocks-in-a-presidential-election-year-history-has-a-crazy-stat-for-you">Benzinga previously reported</a> that presidential election years are often good for investors with 14 of the last 16, not including 2024, seeing the S&amp;P 500 Index trade higher. The only two presidential election years of the last 16 to not have a positive return were the global financial crisis (2008) and the dot-com bubble (2000).
The SPDR S&amp;P 500 ETF Trust is currently up 26.4% year-to-date in 2024. While that amount could go up or down, the return is currently among the highest in recent presidential election years.
If the 26.4% gain holds or comes in higher, 2024 would mark the best-performing presidential election year for the S&amp;P 500 since 1980 (+32.4%), beating the current record holder, 1996, which saw the index up 23.1%.
The 2024 return of the S&amp;P 500 could also come as one of the best in recent years. Here are the recent returns of the S&amp;P 500 ETF Trust:
<ul>
<li>2023: +26.2%</li>
<li>2022: -18.2%</li>
<li>2021: +28.8%</li>
<li>2020: +18.4%</li>
<li>2019: +31.2%</li>
<li>2018: -4.6%</li>
<li>2017: +21.7%</li>
<li>2016: +12.0%</li>
</ul>
With the ETF up 26.4% year-to-date, the SPY is currently ahead of the 2023 return, but down from the returns posted in 2021 and 2019.
If the stock market continues to trade higher and hits record highs, there's a chance that the SPY passes those figures and could be the best performing year for the ETF in over 10 years, with 2013 being up 32.3%.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/10/41584466/these-10-stocks-were-the-best-s-p-500-performers-in-2017-when-trump-was-president-will-history-r">These 10 Stocks Were The Best S&amp;P 500 Performers In 2017 When Trump Was President: Will History Repeat Itself?</a></li>
</ul>
The study was conducted by Benzinga from Nov. 6 through Nov. 7, 2024, and included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 146 adults.
Photo: Shutterstock

Politics

Will Trump's Election Win Push S&P 500 Even Higher In Final Weeks Of 2024? Over 75% Say...

Flywire (FLYW – Research Report), the Technology sector company, was revisited by a Wall Street analyst yesterday. Analyst Andrew Schmitt from Citi...

Buy Rating Affirmed: Flywire's Resilience Amidst Australian Visa Policy Changes

Flywire GAAP EPS of $0.30 beats by $0.14, revenue of $156.81M beats by $10.44M

Sees Q4 adjusted EBITDA $15M-$19M Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> S...

Flywire sees Q4 revenue $121M-$129M, consensus $123.4M

Total Payment Volume increased 24.2% to $11.0B in the third quarter of 2024, compared to $8.9B in the third quarter of 2023. Adjusted EBITDA increa...

Flywire reports Q3 total payments volume up 24.2%

Consensus $486.1M Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-...

Flywire narrows FY24 revenue view to $495M-$503M from $483M-$506M

Reports Q3 revenue $156.8M, consensus $148.8M. "Our third quarter results highlight our ability to capture higher payment volumes with new and exis...

Flywire reports Q3 EPS 30c, consensus 15c

Check out this evening's top movers from around Wall Street, compiled by The Fly.&nbsp;&nbsp; HIGHER AFTER EARNINGS – Li-Cycle&nbsp;(LICY)&nbsp;up ...

Closing Bell Movers: Toast gains 19% afterhours after earnings beat

Flywire Corporation ( ($FLYW) ) has released its Q3 earnings. Here is a breakdown of the information Flywire Corporation presented to its investors...

Flywire Corporation Reports Strong Q3 2024 Growth

Flywire Corporation (FLYW) has disclosed a new risk, in the Share Price & Shareholder Rights category. Flywire Corporation faces significant busine...

Flywire's Financial Stability at Risk: Legal Challenges and Stockholder Activism Amid Volatile Markets

Flywire Corporation (FLYW) Q3 2024 Earnings Call Transcript

AAOI

ADMA

AKAM

ALRM

ANET

AXON

BILL

BLZE

CARG

CPRI

DKNG

DOCS

EXPE

FIGS

FIVN

GRND

IOVA

LICY

LITE

PHUN

PINS

RDFN

RVNC

RXST

SERV

STEP

SYNA

VCTR

Press Releases

One Inc Names Micheal Ellis as Chief Financial Officer

Flywire Acquires Invoiced to Bolster its Global B2B Payment Network with Award-winning Accounts Receivable SaaS Platform

Flywire Reports Second Quarter 2024 Financial Results

Balderton Announces $1.3B in New Funds to Back Europe's Top Entrepreneurs as They Build World-Changing Businesses

Flywire to Attend Upcoming Investor Conferences

Flywire showcases strength in U.S. higher education business at its inaugural client conference

Flywire to Announce Third Quarter 2024 Results on November 7, 2024

Flywire Survey Uncovers Increasing Demand for Flexible, Patient-Centric Payment Solutions in U.S. Healthcare

Flywire Reports Third Quarter 2024 Financial Results

TLND

Affirm Holdings, Inc. - Class A Common Stock

Affirm Holdings

AvidXchange Holdings, Inc. - Common Stock

AvidXchange Holdings

Corpay

DLocal

Euronet Worldwide

Evertec

Fiserv

Fidelity National Information Services, Inc. Common Stock

Fidelity National Info

Shift4 Payments, Inc. Class A Common Stock

Shift4 Payments

Global Payments

Jack Henry & Associates, Inc. - Common Stock

Jack Henry & Associates

Mastercard

NCR Atleos

PagSeguro Digital Ltd. Class A Common Shares

PagSeguro Digital

Paymentus Holdings, Inc. Class A Common Stock

Paymentus Holdings

Payoneer Global

PayPal Holdings

Remitly Global

Sezzle

Block

StoneCo

Toast

Visa

Western Union

Morgan Stanley

Raymond James

Wells Fargo

B. Riley Securities

JP Morgan

2024년 11월 8일 기준, 금융 섹터의 3종목의 주식이 모멘텀을 중요하게 여기는 투자자들에게 실질적인 경고 신호를 보낼 수 있다.
상대 강도 지수(RSI)는 모멘텀 지표로, 주가가 상승하는 날의 강도와 하락하는 날의 강도를 비교한다. 주가 행동과 비교할 때, 주식이 단기적으로 어떻게 수행될 수 있는지를 더 잘 이해할 수 있다. <a href="https://pro.benzinga.com/">Benzinga Pro</a>에 따르면, 일반적으로 <a href="https://www.benzinga.com/topic/rsi">RSI가 70 이상</a>일 때 자산이 과매수 상태로 간주된다.
다음은 이 섹터에서 주요 과매수 주식 목록이다.
<h3 class="wp-block-heading">업스타트 홀딩스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>)</h3>
<ul>
<li>11월 7일, 업스타트는 주당 7센트의 분기 손실을 보고하였으며, 이는 15센트 손실에 대한 애널리스트의 컨센서스 예상을 초과한 결과이다. 분기 매출은 1억 6,214만 달러로, 애널리스트의 컨센서스 예측인 1억 5,022만 달러를 초과하며, 작년 동기 매출인 1억 3,455만 달러에 비해 증가했다. 업스타트의 CEO인 데이브 기루아르(Dave Girouard)는 &#8220;대출량이 전분기 대비 43% 성장하고 조정된 EBITDA가 긍정적으로 돌아오면서, 우리는 인공지능 핀테크 리더로서의 업스타트의 입지를 계속 강화하고 있다. 거시경제로부터의 큰 상승 없이도 우리는 성장 모드로 돌아왔다&#8221;고 말했다. 이 회사의 주가는 지난 한 달 동안 약 89% 상승했으며, <a href="https://www.benzinga.com/quote/UPST">52주 최고가가 82.25달러</a>이다.</li>
<li>RSI 값: 79.08 (목요일 종가 기준)</li>
<li>UPST 주가 변동: 업스타트의 주식은 금요일 46.02% 급등한 81.88달러에 마감했다.</li>
</ul>
<h3 class="wp-block-heading">토스트 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>)</h3>
<ul>
<li>11월 7일, 토스트는 3분기 재무 실적이 예상보다 좋게 나타났다. &#8220;토스트는 강력한 3분기를 기록하며 약 7,000개의 새로운 매장을 추가하고, 반복적인 총 이익 수익이 35% 증가했으며, 조정된 EBITDA가 1억 1,300만 달러에 달했다. 우리는 올해를 강하게 마무리하고 2025년으로 이 모멘텀을 이어갈 수 있는 좋은 위치에 있다&#8221;고 토스트의 CEO이자 공동 창립자인 아만 나랑(Aman Narang)이 말했다. 이 회사의 주가는 지난 한 달 동안 30.14% 상승했으며, <a href="https://www.benzinga.com/quote/TOST">52주 최고가가 38.40달러</a>이다.</li>
<li>RSI 값: 85.15 (목요일 종가 기준)</li>
<li>TOST 주가 변동: 토스트의 주식은 금요일 14.72% 상승하여 37.48달러에 거래를 마쳤다.</li>
</ul>
<h3 class="wp-block-heading">플라이와이어 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYW#NASDAQ">FLYW</a>)</h3>
<ul>
<li>11월 7일, 플라이와이어는 3분기 재무 실적이 예상보다 좋았고, 2024회계연도 매출 가이던스가 예상치를 상회한다고 발표했다. &#8220;3분기 실적은 새로운 고객 및 기존 고객과의 높은 결제량을 포착할 수 있는 우리의 능력을 강조한다. 이는 우리의 계정 및 수직 시장 내 성장 잠재력을 나타낸다&#8221;고 플라이와이어의 CEO인 마이크 마사로(Mike Massaro)가 말했다. 이 회사의 주가는 지난 한 달 동안 27.29% 상승했으며, <a href="https://www.benzinga.com/quote/FLYW">52주 최고가가 31.54달러</a>다.</li>
<li>RSI 값: 77.08 (목요일 종가 기준)</li>
<li>FLYW 주가 변동: 플라이와이어의 주식은 금요일 14.70% 상승하여 20.99달러로 마감했다.</li>
<li></li>
</ul>
더 읽어보기: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/41820056/how-to-earn-500-a-month-from-nvidia-stock-after-trump-win">트럼프 당선 이후 엔비디아 주식으로 매달 500달러를 버는 방법</a></li>
</ul>
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Flywire

뉴스

에 대한 최신 뉴스 Flywire (NASDAQ:FLYW) 주식

금요일, 11월 08, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌